Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
Nuclear Medicine Communications
|
October 9, 2013
Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer
Volkan Beylergil, Patrick G Morris, Peter M Smith-Jones, et al.
Radiology
|
June 10, 2020
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted <sup>89</sup>Zr-Pertuzumab PET/CT
Gary A Ulaner, Jorge A Carrasquillo, Christopher C Riedl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2019
Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer
Christian Lohrmann, Eileen M O'Reilly, Joseph A O'Donoghue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2022
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using <sup>89</sup>Zr-Trastuzumab PET: A Pilot Study
Melissa A Lumish, Steven B Maron, Viktoriya Paroder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2020
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study
Shakeel Modak, Pat Zanzonico, Milan Grkovski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 7, 2016
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
Gary A Ulaner, David M Hyman, Dara S Ross, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 23, 2017
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for <sup>89</sup>Zr-Trastuzumab in Patients with Esophagogastric Cancer
Joseph A O'Donoghue, Jason S Lewis, Neeta Pandit-Taskar, et al.
EJNMMI Radiopharmacy and Chemistry
|
July 19, 2022
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals
Aruna Korde, Renata Mikolajczak, Petra Kolenc, et al.
EJNMMI Research
|
October 8, 2024
[<sup>18</sup>F]TFB PET/CT misses intense [<sup>124</sup>I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer
Philipp Backhaus, Keith S Pentlow, Alan L Ho, et al.
The Lancet. Oncology
|
June 20, 2018
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
Mark M Souweidane, Kim Kramer, Neeta Pandit-Taskar, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
Nuclear Medicine Communications
|
October 9, 2013
Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer
Volkan Beylergil, Patrick G Morris, Peter M Smith-Jones, et al.
Radiology
|
June 10, 2020
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted <sup>89</sup>Zr-Pertuzumab PET/CT
Gary A Ulaner, Jorge A Carrasquillo, Christopher C Riedl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2019
Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer
Christian Lohrmann, Eileen M O'Reilly, Joseph A O'Donoghue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2022
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using <sup>89</sup>Zr-Trastuzumab PET: A Pilot Study
Melissa A Lumish, Steven B Maron, Viktoriya Paroder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2020
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study
Shakeel Modak, Pat Zanzonico, Milan Grkovski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 7, 2016
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
Gary A Ulaner, David M Hyman, Dara S Ross, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 23, 2017
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for <sup>89</sup>Zr-Trastuzumab in Patients with Esophagogastric Cancer
Joseph A O'Donoghue, Jason S Lewis, Neeta Pandit-Taskar, et al.
EJNMMI Radiopharmacy and Chemistry
|
July 19, 2022
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals
Aruna Korde, Renata Mikolajczak, Petra Kolenc, et al.
EJNMMI Research
|
October 8, 2024
[<sup>18</sup>F]TFB PET/CT misses intense [<sup>124</sup>I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer
Philipp Backhaus, Keith S Pentlow, Alan L Ho, et al.
The Lancet. Oncology
|
June 20, 2018
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
Mark M Souweidane, Kim Kramer, Neeta Pandit-Taskar, et al.
Page
of 8